Connor, Clark & Lunn Investment Management Ltd.
Position in INFU — InfuSystem Holdings, Inc
CIK 1596800
VANCOUVER, A1
Position in INFU
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$802,947
+$144,285 QoQ
Shares Held
83,207
+16.6% QoQ
Ownership
0.418%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 98 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INFU Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $204,731,115 across 26 Medical Devices names. INFU ranks #14 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
869,131 | $78,864,946 | |
| 2 | BSX |
Boston Scientific Corp
|
1,467,148 | $62,617,875 | |
| 3 | PHG |
Koninklijke Philips NV
|
563,724 | $15,327,654 | |
| 4 | SNN |
Smith & Nephew PLC
|
487,774 | $14,052,767 | |
| 5 | NVCR |
NovoCure Ltd
|
661,280 | $10,018,391 | |
| 6 | IRTC |
iRhythm Holdings, Inc.
|
42,314 | $5,033,250 | |
| 7 | AXGN |
Axogen, Inc.
|
67,118 | $3,100,180 | |
| 8 | VREX |
Varex Imaging Corp
|
293,435 | $3,060,526 |
All Filings in INFU
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $802,947 | 83,207 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $658,662 | 71,361 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $694,968 | 77,477 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,063,319 | 102,637 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $435,377 | 69,772 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $270,172 | 50,218 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $204,304 | 24,178 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $86,932 | 12,975 | Shares | Sole | 2024-11-08 | |
| No filing history on record for this holder in this stock. | ||||||